Umang Swami

3.1k total citations
173 papers, 1.6k citations indexed

About

Umang Swami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Umang Swami has authored 173 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pulmonary and Respiratory Medicine, 91 papers in Oncology and 47 papers in Cancer Research. Recurrent topics in Umang Swami's work include Prostate Cancer Treatment and Research (78 papers), Cancer Immunotherapy and Biomarkers (39 papers) and Radiopharmaceutical Chemistry and Applications (28 papers). Umang Swami is often cited by papers focused on Prostate Cancer Treatment and Research (78 papers), Cancer Immunotherapy and Biomarkers (39 papers) and Radiopharmaceutical Chemistry and Applications (28 papers). Umang Swami collaborates with scholars based in United States, United Kingdom and Spain. Umang Swami's co-authors include Neeraj Agarwal, Sanjay Goel, Taylor Ryan McFarland, Roberto Nussenzveig, Mohammed Milhem, Yousef Zakharia, Sridhar Mani, Nicolas Sayegh, Benjamin L. Maughan and Nishita Tripathi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Umang Swami

147 papers receiving 1.6k citations

Peers

Countries citing papers authored by Umang Swami

Since Specialization

Citations

This map shows the geographic impact of Umang Swami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umang Swami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umang Swami more than expected).

Fields of papers citing papers by Umang Swami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umang Swami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umang Swami. The network helps show where Umang Swami may publish in the future.

Co-authorship network of co-authors of Umang Swami

This figure shows the co-authorship network connecting the top 25 collaborators of Umang Swami. A scholar is included among the top collaborators of Umang Swami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umang Swami. Umang Swami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer 2025 ·Clinical Cancer Research ·(unknown), Ryon P. Graf, (unknown), (unknown), Nicolas Sayegh, Gerald Li, Benjamin L. Maughan, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami	0
2	Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial 2024 ·BMC Cancer ·Adriana M. Coletta, (unknown), (unknown), Sarah Taylor, (unknown), Pamela A. Hansen, Vinay Mathew Thomas, Cornelia M. Ulrich, Manish Kohli, Jonathan Chipman, Umang Swami, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal	1
3	PD09-05 DIFFERENCES IN GENOMIC, TRANSCRIPTOMIC AND IMMUNE LANDSCAPE OF PROSTATE CANCER (PCA) BASED ON SITE OF METASTASIS (METS) 2024 ·The Journal of Urology ·Dhruv Puri, Umang Swami, Georges Gebrael, Shayan Nazari, Andrew Elliott, Chadi Nabhan, Rana R. McKay, Emmanuel S. Antonarakis, Aditya Bagrodia, Neeraj Agarwal	1
4	Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials 2024 ·JAMA Network Open ·Sanjay Goel, Abdissa Negassa, Mohammad H. Ghalib, Imran Chaudhary, Kavita Desai, Umang Shah, Umang Swami, (unknown), Radhashree Maitra, Sridhar Mani	0
5	1966MO EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC) 2024 ·Annals of Oncology ·Thomas Powles, Michiel S. van der Heijden, Shilpa Gupta, Begoña P. Valderrama, (unknown), (unknown), Eiji Kikuchi, Jean Hoffman‐Censits, J.P. Maroto Rey, Christof Vulsteke, Gopa Iyer, Umang Swami, Sang Joon Shin, Alejo Rodríguez‐Vida, Michał Woźniak, Blanca Homet Moreno, Jie Lu, Changjun Yu, Leah J. Hogdal, Yohann Loriot	13
6	Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI 2024 ·JCO Precision Oncology ·Vinay Mathew Thomas, (unknown), Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Roberto Nussenzveig, Yeonjung Jo, (unknown), (unknown), (unknown), Kamal Kant Sahu, (unknown), Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	1
7	Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate Carcinoma 2024 ·Diagnostics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Georges Gebrael, Neeraj Agarwal, Umang Swami, (unknown)	1
8	Phase I/II trial of LAVA-1207, a novel bispecific gamma-delta T-cell engager alone, or with low dose IL-2 or pembrolizumab, in metastatic castration resistant prostate cancer (mCRPC). 2024 ·Journal of Clinical Oncology ·Niven Mehra, Jens Voortman, David R. Wise, Emiliano Calvo, Josep M. Piulats, Enrique González‐Billalabeitia, (unknown), Umang Swami, Joel Picus, (unknown), Teeru Bihani, Jurjen M. Ruben, (unknown), Hans van Vliet, Marya Chaney, Debbie Robbrecht	4
9	Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor 2024 ·Cancer ·Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, (unknown), Nicolas Sayegh, Nishita Tripathi, (unknown), (unknown), (unknown), (unknown), (unknown), Patrick Campbell, (unknown), (unknown), Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2
10	Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting 2024 ·The Prostate ·Georges Gebrael, (unknown), Nicolas Sayegh, Nishita Tripathi, (unknown), (unknown), (unknown), Taylor Ryan McFarland, (unknown), (unknown), (unknown), (unknown), Yeonjung Jo, (unknown), Vinay Mathew Thomas, Kamal Kant Sahu, Haoran Li, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal	1
11	A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome 2023 ·Frontiers in Immunology ·(unknown), Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami, (unknown), (unknown), Heloisa P. Soares, (unknown), (unknown), Jennifer A. Doherty, John Hyngstrom, Sheetal Hardikar, Siwen Hu‐Lieskovan	16
12	Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas 2023 ·Cancers ·Haoran Li, Kamal Kant Sahu, (unknown), Nishita Tripathi, Nicolas Sayegh, (unknown), (unknown), Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	1
13	Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer 2023 ·JAMA Network Open ·Nicolas Sayegh, Umang Swami, Yeonjung Jo, Georges Gebrael, Benjamin Haaland, Shilpa Gupta, Melissa Plets, Maha Hussain, David I. Quinn, Primo N. Lara, Ian M. Thompson, Neeraj Agarwal	5
14	Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data 2023 ·Clinical Genitourinary Cancer ·Umang Swami, (unknown), Mo Zhou, Shan Jiang, Jeri Kim, (unknown), François Laliberté, Bruno Émond, Neeraj Agarwal	6
15	Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden 2023 ·Journal for ImmunoTherapy of Cancer ·Vaia Florou, Charalampos S. Floudas, Asaf Maoz, Abdul Rafeh Naqash, (unknown), Aik Choon Tan, Ethan Sokol, Garrett M. Frampton, Heloisa P. Soares, Sonam Puri, Umang Swami, Breelyn A. Wilky, Peter J. Hosein, Jonathan C. Trent, Gilberto Lopes, Wungki Park, Ignacio Garrido‐Laguna	9
16	External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer 2022 ·Molecular Cancer Therapeutics ·Umang Swami, Nicolas Sayegh, Yeonjung Jo, Benjamin Haaland, Taylor Ryan McFarland, Roberto Nussenzveig, (unknown), Deepika Sirohi, Andrew W. Hahn, Benjamin L. Maughan, Amir Goldkorn, Neeraj Agarwal	5
17	A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers 2022 ·Heliyon ·(unknown), Kamal Kant Sahu, (unknown), (unknown), Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2
18	Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting 2022 ·Biomedicines ·Taylor Ryan McFarland, Vinay Mathew Thomas, Roberto Nussenzveig, Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Kamal Kant Sahu, (unknown), Benjamin L. Maughan, Deepika Sirohi, Neeraj Agarwal, Umang Swami	2
19	SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer 2022 ·Clinical Cancer Research ·Umang Swami, Ryon P. Graf, Roberto Nussenzveig, Virginia Fisher, Hanna Tukachinsky, Alexa B. Schrock, Gerald Li, Jeffrey S. Ross, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Geoffrey R. Oxnard, Emmanuel S. Antonarakis, Neeraj Agarwal	40
20	Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform 2021 ·The Oncologist ·Edwin Lin, Andrew W. Hahn, Roberto Nussenzveig, (unknown), Nicolas Sayegh, Benjamin L. Maughan, Taylor Ryan McFarland, Nityam Rathi, Deepika Sirohi, Guru Sonpavde, Umang Swami, Manish Kohli, Thereasa A. Rich, Oliver Sartor, (unknown), Neeraj Agarwal	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact